**Core Concept**
Hyperglycemia refers to elevated blood glucose levels, commonly due to insulin deficiency or resistance. It is often associated with metabolic disorders, endocrine dysfunction, or conditions affecting glucose metabolism. Certain genetic, metabolic, or neoplastic diseases can cause hyperglycemia through disrupted insulin action or increased glucose production.

**Why the Correct Answer is Right**
Sarcoma, a malignant tumor of connective tissue, is not directly associated with hyperglycemia. While some tumors can cause metabolic disturbances, sarcoma does not typically lead to insulin resistance or glucose dysregulation. In contrast, cirrhosis (Option A) causes hyperglycemia due to impaired insulin action and reduced glucose utilization. Myotonic dystrophy (Option B) involves insulin resistance and glucose intolerance. Lipodystrophy (Option C) leads to severe insulin resistance due to lack of adipose tissue, which normally stores and regulates glucose. Thus, sarcoma is the only option not linked to hyperglycemia.

**Why Each Wrong Option is Incorrect**
Option A: Cirrhosis causes hyperglycemia due to impaired insulin sensitivity and reduced adipose tissue, leading to insulin resistance.
Option B: Myotonic dystrophy is a genetic disorder with insulin resistance and impaired glucose metabolism, resulting in hyperglycemia.
Option C: Lipodystrophy lacks adipose tissue, which normally buffers glucose and releases fatty acids; this leads to insulin resistance and hyperglycemia.

**Clinical Pearl / High-Yield Fact**
Always remember: **"Lipodystrophy, cirrhosis, and myotonic dystrophy cause hyperglycemia; sarcoma does not."** This is a classic exam trap—neoplasms like sarcoma may cause metabolic issues, but not hyperglycemia specifically.

✓ Correct Answer: D. Sarcoma